Intravenous Anesthetic Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025

Intravenous Anesthetic Market Size, Share and Industry Analysis by Patient Type (Paediatric/Infants, and Adults), By Drug (Barbiturates, Non-Barbiturates, Dissociatives, and others) By End User (Hospitals and Clinics, Specialty Centers, and Ambulatory Centers), By Region (North America, Europe, Asia-Pacific, and Rest of the World), Competitive Market Share & Forecast, 2019 - 2025

The global intravenous anesthetic market is expected to reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx% during the forecast period. Global intravenous anesthetic market report covers market size, market share and market forecast by product types, gender, regions, and key players, with historical data along with forecast from 2019 to 2025. The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.

Intravenous Anesthetic Market Outlook:

Anesthetics are the components or drugs that are administered to induce a state of impaired awareness or for complete sedation. Anesthetic agents are administered via various routes including; parenteral, inhalation, rectal and so on. Intramuscular (IM), subcutaneous (SC) and intravenous (IV) are the common parenteral routes to administer anesthetics. The intravenous anesthetic market report focuses mainly on the drugs that are administered directly into the vein. Commonly used intravenous anesthetics include sedative-hypnotic agents such as barbiturates such as oxybarbiturate, non-barbiturates such as propofol, etomidate, and dissociatives such as ketamine. These drugs are commonly used to induce and maintain general anesthesia and sedation.  

Administration of intravenous anesthesia began back in 1930’s after introduction of thiopental. Since then, number of drugs such as propofol, ketamine, etomidate, dexmedetomidine, and benzodiazepines represent some of the more significant contributions to sedative agents or intravenous anesthetic market. With evolvement of derivatives and alternatives, the efficacy level of these drugs has also been improved. After intravenous injection, these induction agents have rapid onset due to their high lipid solubility allowing penetration of the blood–brain barrier, and the high proportion of the cardiac output that perfuses the brain. These drugs also have a short duration of action due to rapid redistribution from the brain to other tissues, primarily muscle and fat. Typically, one or more supportive medication is administered to supplement stimulation of general anesthesia.

Intravenous Anesthetic Market Trends and Advancements:

An ideal anesthesia technique is one that has rapid onset and fast recovery, with minimal cardiovascular and other side effects. While science is still in search of the holy grail of anesthesia care, many developments have been made in the past two decades that have resulted in improved safety and outcomes of anesthetic techniques. In the intravenous anesthetic market, technologies such as target-controlled infusion (TCI) has evolved immensely from a research tool into a now-routine part of anesthesia delivery in many countries across the world. Advancement in this target-controlled infusion technology has the potential to expand the precision, efficacy, reliability, and safety of intravenous anesthesia delivery. With continuous research and development in the field of anesthesia, researchers continue to develop both new formulations of the existing agents and advanced chemical entities in strides to improve safety, efficacy, onset, predictability, and recovery profile and to minimize side effects.

Along with hospitals, clinics, and speciality centers, ambulatory centers are also adopting intravenous anesthesia as the sole technique for provision of ambulatory anesthesia care, also known as total intravenous anesthesia. Ambulatory applications resulted mainly as a result of the advancement in pharmacokinetics and pharmacodynamics of injectable anesthetic agents. Along with this, effective clinical outcomes of the intravenous anesthetics also played a vital role in its utilization in ambulatory care. Such expansion of end use application will address the impact of several newer intravenous anesthetics on the evolution of ambulatory anesthesia. Thus, is expected to be a significant opportunity for the development of intravenous anesthetic market.

Intravenous anesthetic market Drivers and Restraints:

Growth of the global intravenous anesthetic market is mainly driven by growing volume of surgical procedures across numerous therapeutic categories including orthopedic, general surgeries, cardiac, and others. The number of orthopedic surgeries are expected to reach 6.6 million by the end of 2020 from 5.3 million in 2010. Also, there are approximately 340,000 coronary artery bypass grafting (CABG) surgeries are performed each year in the US. Such increasing number of surgeries are primarily driving the growth of intravenous anesthetic market. Moreover, increasing development of healthcare facilities in emerging economies and advancements in the anesthesia drug delivery methods, such as jet injection, administration of general anesthesia especially in complex surgeries, and increasing adoption of intravenous anesthesia in ambulatory care are some of the additional factors contributing to the market growth and increasing market size. However, side effects associated with anesthesia drugs such as allergy, nausea, vomiting, and complications during surgical procedures are likely to restraint the growth of the market. Additionally, factors such as lack of skilled anesthesiologist, inadequate insurance coverage and high prices of these drugs also impact the growth of intravenous anesthesia market in a negative way.

Intravenous anesthetic market Segmentation and Geographic Outlook:

The intravenous anesthetic market is segmented on the basis of drug, patient type, end user and geography. On the basis of drug, the market is segmented into barbiturates, non-barbiturates, dissociatives, and others. The patient type segment is divided into pediatric/infants, and adults. By end user the market is segmented into hospitals and clinics, specialty centers, and ambulatory centers. Geographic breakdown and deep analysis of each of the segments mentioned above is included for North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market by holding maximum market share of the global intravenous anesthetic market. However, Asia-Pacific is expected to experience a fastest growth during the forecast period. Huge population base, developing healthcare infrastructure, increasing number of surgical procedures due to affordability and rapidly growing pharmaceutical industry in countries like India and China are largely contributing to the market growth in this region.

Intravenous anesthetic market Competitive Landscape:

The intravenous anesthetic market is largely competitive due to presence of enormous number of established as well as emerging players. In order to sustain in the competitive market and maintain their market position companies mainly focus on research and development as their primary growth strategy. Along with this, the players also collaborate with government as well as private organizations to develop their market presence.

A comprehensive and competitive analysis of market leaders is provided in this report. Some of the major players operating in the global intravenous anesthetic market include Hospira, Novartis, Eisai, Roche, Astra Zeneca, Johnson & Johnson, GSK, Baxter, Primex Pharmaceuticals, and Abbott.

What you get from the Intravenous Anesthetic Market research report:

  • The study provides an in-depth analysis of the intravenous anesthetic market with current and future trends to explain the imminent investment pockets in the market
  • Current and future trends are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold in the market
  • The report provides information regarding key drivers, restraints and opportunities with impact analysis
  • Quantitative analysis of the current market and estimations through 2018-2025 are provided to showcase the financial caliber of the market
  • Porters Five Forces model and SWOT analysis of the industry illustrates the potency of the buyers & suppliers participating in the market
  • Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain

Request Table on Content for Intravenous Anesthetic Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025

security code:

Request Tables and Figures for Intravenous Anesthetic Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025

security code:

Choose License Type



Why Choose Us

  • 24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.